Press Release Summary:
- Provides 99.9% mitigation of mold, mildew, aspergillus and other harmful pathogens with nominal to no effects on product
- Builds on short bandwidth remediation methods adopted by multiple research, anti-viral, food and medical industries
- Suitable for blood treatment to sterile insect technique and phytosanitary research by the USDA
Original Press Release:
Rad Source Highlights Cannabis Industry’s Most Effective Mold and Pathogen Removal Technology
Photonic Decontamination powered by patented QUASTAR® technology gives users the power to PASS State Microbial Testing The First Time, Every Time.
New Orleans, LA (June 27, 2019) -- Rad Source Technologies, Inc. (Rad Source, Buford, GA) highlighted the cannabis industry’s most effective mold, mildew, aspergillus and pathogen remediation technology at the MJBizConNEXT conference (Ernest N. Morial Convention Center, Booth #1103, June 12-14).
Attendees saw and learned more about the company’s RS™ 420 series of Cannabis Photonic Decontamination units on the show floor. Rad Source’s technical and scientific experts were on hand to address questions and provide insight to brand owners, investors, growers, and cultivators.
The RS™ 420 Decontamination units are powered by QUASTAR®, the company’s patented photonic emitting technology, and is the only solution on the market that can provide 99.9% mitigation of mold, mildew, aspergillus, and other harmful pathogens with nominal to no effects on product.
QUASTAR®’s Photonic Decontamination is a disruptive new technology that builds on widely-used short bandwidth remediation methods adopted by multiple research, anti-viral, food, and medical industries. The technology is used internationally by the International Atomic Energy Agency (IAEA) and in the United States for applications ranging from blood treatment (GVHD) to Sterile Insect Technique (SIT) and Phytosanitary Research by the USDA. Over the past 20 years, Rad Source has installed nearly 500 units worldwide in the blood, insect, viral inactivation, immunology, and cancer research fields.
“We’ve leveraged our decades of research, technical innovation, and the expertise of our in-house Ph.D.’s and engineering staff in order to provide the cannabis industry the most effective solution to improve efficiencies and reduce product loss,” said George Terry, Executive Vice President of Sales and Marketing, Rad Source.
The science behind QUASTAR® technology is a widely-preferred and government supported solution for remediating medical-grade cannabis in the Netherlands and Canada for many years. In the United States, the RS™ 420 product line is rapidly gaining market share and interest with cannabis operations in over a dozen states.
Unlike Ozone, RF, LED, UV and other remediation methods, Rad Source’s technology ensures the most effective pathogen decontamination penetration method, while simultaneously maintaining cannabis flower integrity, ensuring no impact on cannabinoids or appearance, and negligible to no impact on terpene levels. In addition, it is among the safest and easiest machines to operate.
The compact, standalone unit easily integrates into existing SOPs, and operates on standard 220-volt electrical systems. The units can process 2, 5 or 50 pounds of product in hours, depending on the bioburden of the target and the unit being used. Financing is also now available through an accredited Rad Source leasing partner. For more information or to inquire about financing options, visit: www.radsource.com/cannabis.
Founded in 1997, Rad Source Technologies is a trusted and proven medical device manufacturer providing global solutions for applications ranging from blood, cannabis, cancer, immunology, and insects to cell and food research. Its equipment resides in major pharmaceutical labs, healthcare institutions and renowned universities around the world. Headquartered in Buford, Georgia, USA, with operations world-wide, Rad Source’s highly qualified and dedicated staff continues to provide tailored and effective solutions aimed at safely eliminating dangerous pathogens.